-3.29% for MercadoLibre stock as earnings miss weighs on sentiment

Traders Union
All News
Financial News
MercadoLibre slides 3.29% after earnings miss

All news

Editors' Picks

Crypto News

Financial News

Market Voices

Billionaires

Companies

Broker News

Regulators News

Andrey Mastykin

11.05.2026

-3.29% for MercadoLibre stock as earnings miss weighs on sentiment — MercadoLibre slides 3.29% after earnings miss

MercadoLibre Inc (MELI) is trading at $1,578.82 after a daily decline of 3.29%. The price sits below its key moving averages, highlighting persistent downward pressure.

MELI price prediction

24H -0.02%

$1634.5

48H -0.82%

$1621.43

7D -2.17%

$1599.31

1M -8.56%

$1494.86

3M -16.13%

$1371.03

6M -18.23%

$1336.68

12M -34.7%

$1067.57

Detailed

Current price: $ 1634.78 -3.7600 0.23%

Closed 06/04

Daily range 1616.71

1682.52

Weekly range 1629.52

1733.78

Highlights

MercadoLibre's Q1 2026 EPS of $8.23 missed consensus, underscoring net margin pressure and dampened investor sentiment.
Large-scale share sales by Baillie Gifford & Co and new buying by Michael Burry highlight shifting institutional positioning amid ongoing selling pressure.
MELI remains under strong downside momentum, trades below key averages, and is expected to move sideways in the $1,540–$1,620 range with high risk of further decline.

Institutional selling and earnings miss drive ongoing investor caution

MercadoLibre reported its Q1 2026 earnings on May 7, showing revenue of $8.85 billion and a net margin of 6.04%, but earnings per share of $8.23 missed consensus by $0.52, indicating margin pressure and weighing on investor sentiment. Additionally, Baillie Gifford & Co reduced its stake in the company during the quarter, selling 248,304 shares valued at about $478.99 million, which contributed to further supply in the market. Michael Burry disclosed the establishment of a new full position in MercadoLibre at post-earnings levels, reflecting renewed individual interest, though price action has remained under broader selling pressure.

Momentum stalls amid oversold signals and resistance at Kijun level

MELI is trading below the SMA-20 at $1,823.39, SMA-50 at $1,757.22, and SMA-200 at $2,077.99, with the Ichimoku Kijun level at $1,764.00 forming immediate resistance above the current price. The daily MACD remains neutral but negative, and the ADX is low, highlighting a lack of clear trend. Both daily RSI and CCI signal oversold conditions, and the Stoch RSI is deeply oversold. BBP readings are sharply negative, confirming ongoing seller dominance within the session's wide and volatile intraday range.

Renewed downside risk dominates as volatility constrains potential rebound

Over the next five trading days, MELI is expected to fluctuate within a typical volatility band of $1,540 to $1,620, reflecting recent price action and observed volatility. The probability of continued downward movement is assessed as very high, with further declines below $1,540 likely if current selling persists. Alternatively, a sustained break above $1,620 could open a path toward the Kijun resistance level, but near-term rebound potential remains limited.

Anton Kharitonov, analyst at Traders Union, sees MercadoLibre under clear selling pressure after the Q1 2026 EPS miss and institutional outflows. He notes that the stock remains below all major moving averages, with no strong technical reversal signal in place. Oversold readings and new notable buyers have failed to reverse the cautious sentiment. "Base case remains downside as long as MELI stays under $1,620 — rebounds are unlikely to hold while sellers dominate."

Earlier, analysts noted that MercadoLibre was under sustained selling pressure and faced a prevailing bearish outlook despite strong revenue growth. The current article confirms this negative trend has persisted, and with technical and sentiment indicators remaining weak, traders should closely monitor for a potential break below $1,540, which could amplify downside risks in the near term.

Source of Data: MELI Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.